[Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass].
CONCLUSIONS: This study confirms the accuracy of HE4, ROMA, and CPH-I for differentiating malignant from benign ovarian mass, and all these 3 tests show better performance than CA125. Furthermore, HE4 and CPH-I is superior to ROMA and CA125 in terms of specificity, while CA125 and ROMA have better diagnostic sensitivities.
PMID: 31907150 [PubMed - in process]
Source: Journal of Southern Medical University - Category: Universities & Medical Training Authors: Shipeng G, Yongning C, Yadi Z, Chanyuan LI, Qifan J Tags: Nan Fang Yi Ke Da Xue Xue Bao Source Type: research
More News: Borderline Tumor | Cancer | Cancer & Oncology | China Health | Epithelial Cancer | Ovarian Cancer | Ovaries | Study | Universities & Medical Training | Women